Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 5.6B | 5.7B | 5.8B |
Cost of revenue | 4.5B | 4.6B | 4.6B | 4.7B |
Gross profit | 879M | 1.0B | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 62M | 61M | 55M | 62M |
Other operating expenses | 30M | 33M | 28M | 29M |
Operating income | 787M | 932M | 987M | 1.0B |
Non operating interest income | ||||
Income | 25M | 25M | 28M | 22M |
Expense | 111M | 109M | 113M | 114M |
Other income expense | -395M | -55M | -168M | -20M |
Pretax income | 306M | 793M | 734M | 920M |
Tax provision | 103M | 179M | 154M | 207M |
Net income | 203M | 614M | 580M | 713M |
Basic EPS | 0.2 | 0.7 | 0.7 | 0.8 |
Diluted EPS | 0.2 | 0.7 | 0.7 | 0.8 |
Basic average shares | 866M | 875M | 881M | 884M |
Diluted average shares | 866M | 875M | 881M | 886M |
EBITDA | 1.1B | 1.2B | 1.2B | 1.3B |
Net income from continuing op. | 203M | 614M | 580M | 713M |
Minority interests | 1M | 1M | -9M | -4M |
Preferred stock dividends | — | — | — | — |